05-21-2008, 11:05 AM
HealthDay - TUESDAY, May 20 (HealthDay News) -- The cancer drug sorafenib
(Nexavar) shows promise as a treatment for pulmonary hypertension,
according to a University of Chicago Medical Center study.
Posted on Tue, 20 May 2008 23:01:47 GMT at http://us.rd.yahoo.com/dailynews/rss/hea...ungdisease
(Nexavar) shows promise as a treatment for pulmonary hypertension,
according to a University of Chicago Medical Center study.
Posted on Tue, 20 May 2008 23:01:47 GMT at http://us.rd.yahoo.com/dailynews/rss/hea...ungdisease